Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/112927
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Chemotherapy-induced gut toxicity and pain: involvement of TLRs
Author: Gibson, R.
Coller, J.
Wardill, H.
Hutchinson, M.
Smid, S.
Bowen, J.
Citation: Supportive Care in Cancer, 2016; 24(5):2251-2258
Publisher: Springer
Issue Date: 2016
ISSN: 0941-4355
1433-7339
Statement of
Responsibility: 
Rachel J. Gibson, Janet K. Coller, Hannah R. Wardill, Mark R. Hutchinson, Scott Smid, Joanne M. Bowen
Abstract: Purpose: Chemotherapy-induced gut toxicity is associated with significant pain, and pain influences gut function. Toll-like receptors (TLRs) that regulate gut homeostasis are activated by tissue damage and microbes, and their altered expression following chemotherapy may change cellular responses. This study examined the interaction between chemotherapy-induced gut toxicity and pain and related these to gut TLR and glial fibrillary acidic protein (GFAP) expression. Methods: Female tumor bearing Dark Agouti rats received irinotecan (175 mg/kg, n = 34) or vehicle (n = 5) and were assessed over 120 h for gut toxicity (diarrhea, weight loss), pain (facial), and GFAP, TLR2, 4, 5, and 9 gut expression. Results: Irinotecan caused diarrhea (72 % of animals grade ≥ 1), weight loss (11.1 ± 6.6 %, P < 0.0001), and pain (5 (0–5), P < 0.0001) all peaking at 72 h. Higher pain scores were observed in rats with diarrhea versus those without: median (range) of 2.0 (0–5) versus 0 (0–5), P = 0.01. Irinotecan also caused a decrease in TLR4 and 5, and an increase in GFAP expression in jejuna crypt at 96 and 120 h (all P < 0.05); with lower TLR4 expression associated with lower pain (P = 0.012). Conclusions: The association between gut toxicity and pain suggests these toxicities are linked, possibly via TLR-mediated inflammatory pathways. Further, as TLR4 and 5 expression was absent during recovery in the jejuna and GFAP expression was increased in the jejuna, this implies expression of these may be critical in the healing phase following chemotherapy. Detailed studies of gut TLRs and GFAP are now warranted.
Keywords: Chemotherapy; Gut toxicity; Pain; TLR; GFAP
Rights: © Springer-Verlag Berlin Heidelberg 2015
DOI: 10.1007/s00520-015-3020-2
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.